Skip to main content

Table 4 Adverse events that may be related to Montelukast in the studied patients

From: Role of Montelukast in modulation of response to sepsis in preterm infants: a randomized-controlled trial

Characteristics

Routine care group (n = 20)

Montelukast group (n = 20)

P value

Diarrhea

1

0

0.999

Vomiting

1

1

0.999

Fever

8

7

0.999

Cough

3

4

0.999

Conjunctivitis

1

0

0.999

Liver injury

0

0

 

Skin signs (rash, eczema, bruises, erythematous lesions)

0

0

 
  1. Data expressed as number and analyzed by Fisher’s exact test